QR code

Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials

Background Several cancer therapies have been associated with cardiovascular harm in early‐phase clinical trials. However, some cardiovascular harms do not manifest until later‐phase trials. To limit interdisease variability, we focused on breast cancer. Thus, we assessed the reporting of cardiovasc...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Arsalan Hamid, Markus S. Anker, John C. Ruckdeschel, Muhammad Shahzeb Khan, Arsal Tharwani, Adebamike A. Oshunbade, Rodney K. Kipchumba, Samuel C. Thigpen, Stefan D. Anker, Gregg C. Fonarow, Michael E. Hall, Javed Butler
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Wiley 2022-08-01
Reeks:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Onderwerpen:
cancer therapy
cardio‐oncology
cardiovascular disease
pharmacotherapy
safety
Online toegang:https://www.ahajournals.org/doi/10.1161/JAHA.121.025206
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items